| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.894 | 1.998 | 0 | 0 | - | 207 | 0 | 7.097 | 5.640 | 0 |
| Total Income - EUR | 3.894 | 1.998 | 0 | 0 | - | 207 | 0 | 7.097 | 5.640 | 0 |
| Total Expenses - EUR | 797 | 170 | 0 | 0 | - | 0 | 48 | 13.400 | 17.265 | 9.752 |
| Gross Profit/Loss - EUR | 3.097 | 1.828 | 0 | 0 | - | 207 | -48 | -6.303 | -11.625 | -9.752 |
| Net Profit/Loss - EUR | 2.900 | 1.785 | 0 | 0 | - | 207 | -48 | -6.374 | -11.769 | -9.752 |
| Employees | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Marcomeda Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.603 | 3.566 | 3.506 | 3.442 | - | 3.311 | 3.238 | 3.248 | 3.238 | 3.220 |
| Current Assets | 4.694 | 6.413 | 6.304 | 6.188 | - | 6.160 | 5.773 | 4.248 | 3.636 | 3.616 |
| Inventories | 1.308 | 1.158 | 1.138 | 1.117 | - | 1.075 | 1.051 | 1.054 | 1.051 | 1.045 |
| Receivables | 0 | 1 | 1 | 1 | - | 1 | 1 | 1 | 1.496 | 1.488 |
| Cash | 3.385 | 5.254 | 5.165 | 5.070 | - | 5.084 | 4.721 | 3.193 | 1.089 | 1.083 |
| Shareholders Funds | 7.953 | 9.656 | 9.493 | 9.318 | - | 9.171 | 8.718 | 2.310 | -9.466 | -19.165 |
| Social Capital | 67 | 67 | 66 | 64 | - | 62 | 61 | 61 | 61 | 60 |
| Debts | 344 | 323 | 317 | 312 | - | 300 | 293 | 5.186 | 16.340 | 26.001 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1061 - 1061" | |||||||||
| CAEN Financial Year |
1061
|
|||||||||
Comments - Marcomeda Srl